Peter Erwin, PhD’s Post

View profile for Peter Erwin, PhD, graphic

Vice President at CVP (Customer Value Partners)

CVP @ National Center for Advancing Translational Sciences (NCATS) Proud to share that CVP and our new Atlas Research colleagues have been awarded a 2 year contract to support the National Center for Advancing Translational Sciences (NCATS) Office of Rare Diseases Research (ORDR). We will be supporting the IDeaS (Impact of Rare Diseases on Patients and Healthcare Systems) pilot program providing computational tools, methodologies, and analysis to analyze large healthcare system datasets for the prevalence, healthcare utilization, and cost of undiagnosed and misdiagnosed rare diseases. Our team, along with Professor Keith Crandall, the founding director of the Computational Biology Institute at George Washington University, and his team will be analyzing healthcare data to develop predictive models that can be applied to better identify cases where an individual may be experiencing a rare disease.

Louis DeNino, PhD

Principal at LDN Consulting, LLC

2y

This is a very important project. I’m sure many people will benefit from this work.

Like
Reply

Congratulations. Good to hear of CVP's continuing success. 🎈 🎉 🎈

Like
Reply

This is a great success and I’m excited to see the impact of this body of work. Amazing!

Like
Reply
Patrick Ryan

Independent Consultant at PatRyan Consulting LLC

2y

Peter my friend Jim Laflamme has been working the pharmaceutical aspect of this issue. Let me know if you’d like an intro.

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics